Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steeve Provencher

Showing results (11-20 of 169) with videos related to

Pageof 17
Sort By:
Pulmonary Circulation|July 10, 2014
Vascular remodeling process in pulmonary arterial hypertension, with focus on miR-204 and miR-126 (2013 Grover Conference series)François Potus, Colin Graydon, Steeve Provencher, et al.
Current Vascular Pharmacology|May 30, 2013
Therapeutic Potential of microRNA Modulation in Pulmonary Arterial HypertensionJolyane Meloche, Roxane Paulin, Steeve Provencher, et al.
Trends in Pharmacological Sciences|June 20, 2025
Anti-remodeling therapies in pulmonary arterial hypertensionOlivier Boucherat, Sébastien Bonnet, Steeve Provencher, et al.
Pulmonary Medicine|February 23, 2013
Responsiveness of Various Exercise-Testing Protocols to Therapeutic Interventions in COPDBenoit Borel, Steeve Provencher, Didier Saey, et al.
COPD|December 21, 2010
Reduced heart rate variability in patients with chronic obstructive pulmonary disease independent of anticholinergic or β-agonist medicationsMarie-Eve Bédard, Karine Marquis, Paul Poirier, et al.
Chest|March 15, 2014
Effect of pulmonary arterial hypertension-specific therapies on health-related quality of life: a systematic reviewGilles Rival, Yves Lacasse, Sylvie Martin, et al.
Vascular Pharmacology|May 13, 2023
The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targetsCharifa Awada, Olivier Boucherat, Steeve Provencher, et al.
Plos One|November 24, 2011
Assessment of daily life physical activities in pulmonary arterial hypertensionVincent Mainguy, Steeve Provencher, François Maltais, et al.
Plos One|March 21, 2015
Quality of life, safety and efficacy profile of thermostable flolan in pulmonary arterial hypertensionSteeve Provencher, Patrap Paruchuru, Andrea Spezzi, et al.
American Journal of Respiratory and Critical Care Medicine|December 19, 2015
Bridging Lung Development with Chronic Obstructive Pulmonary Disease. Relevance of Developmental Pathways in Chronic Obstructive Pulmonary Disease PathogenesisOlivier Boucherat, Mathieu C Morissette, Steeve Provencher, et al.
Pageof 17

Showing results (11-20 of 169) with videos related to

Sort By:
Pageof 17
Pulmonary Circulation|July 10, 2014
Vascular remodeling process in pulmonary arterial hypertension, with focus on miR-204 and miR-126 (2013 Grover Conference series)François Potus, Colin Graydon, Steeve Provencher, et al.
Current Vascular Pharmacology|May 30, 2013
Therapeutic Potential of microRNA Modulation in Pulmonary Arterial HypertensionJolyane Meloche, Roxane Paulin, Steeve Provencher, et al.
Trends in Pharmacological Sciences|June 20, 2025
Anti-remodeling therapies in pulmonary arterial hypertensionOlivier Boucherat, Sébastien Bonnet, Steeve Provencher, et al.
Pulmonary Medicine|February 23, 2013
Responsiveness of Various Exercise-Testing Protocols to Therapeutic Interventions in COPDBenoit Borel, Steeve Provencher, Didier Saey, et al.
COPD|December 21, 2010
Reduced heart rate variability in patients with chronic obstructive pulmonary disease independent of anticholinergic or β-agonist medicationsMarie-Eve Bédard, Karine Marquis, Paul Poirier, et al.
Chest|March 15, 2014
Effect of pulmonary arterial hypertension-specific therapies on health-related quality of life: a systematic reviewGilles Rival, Yves Lacasse, Sylvie Martin, et al.
Vascular Pharmacology|May 13, 2023
The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targetsCharifa Awada, Olivier Boucherat, Steeve Provencher, et al.
Plos One|November 24, 2011
Assessment of daily life physical activities in pulmonary arterial hypertensionVincent Mainguy, Steeve Provencher, François Maltais, et al.
Plos One|March 21, 2015
Quality of life, safety and efficacy profile of thermostable flolan in pulmonary arterial hypertensionSteeve Provencher, Patrap Paruchuru, Andrea Spezzi, et al.
American Journal of Respiratory and Critical Care Medicine|December 19, 2015
Bridging Lung Development with Chronic Obstructive Pulmonary Disease. Relevance of Developmental Pathways in Chronic Obstructive Pulmonary Disease PathogenesisOlivier Boucherat, Mathieu C Morissette, Steeve Provencher, et al.
Pageof 17